Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Cephalexin Safety During Breastfeeding

Safety Profile

  • Cephalexin, a first-generation cephalosporin, is considered safe for use during breastfeeding as β-lactam antibiotics generally have minimal adverse effects on nursing infants 1

Clinical Applications

  • The American Academy of Pediatrics and other medical societies recommend cephalexin as a first-line antibiotic option for treating mastitis in breastfeeding women, as it is effective for skin and soft tissue infections 2
  • Continued breastfeeding during antibiotic treatment with cephalexin is recommended as it helps resolve mastitis and does not pose significant risks to the infant 2

Alternative Antibiotics

  • If cephalexin is not tolerated or appropriate, amoxicillin/clavulanic acid is an alternative that is also considered safe during breastfeeding, according to the Infectious Diseases Society of America 2

Monitoring Recommendations

  • If symptoms worsen or do not improve within 48-72 hours of starting cephalexin, reevaluation is necessary to rule out complications or need for alternative antibiotics, as recommended by the American College of Obstetricians and Gynecologists 2

REFERENCES

1

maternal sepsis review and update. [LINK]

Mayo Clinic Proceedings, 2025

2

First-Line Antibiotics for Mastitis in Breastfeeding Women [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025